Biotech news
Biotech
Neuroscience-focused biopharma ends litigation with four companies | Companies can introduce generic alternatives in the future. 14 November 2023
Americas
Controversial rule precludes a patent review if there is parallel litigation | Big pharma and tech companies insist the rule is “arbitrary and capricious” |
US agency backs Vidal’s authority, calling a proposed intervention “unnecessary”. 14 November 2023
Biotech
Federal Circuit rejects appeal in patent dispute with California’s Cloudbreak Theraputics | Court stated failure to prove concrete injury. 9 November 2023
Biotech
RSB Spine files patent infringement lawsuit against competitors over spinal implant products | Plaintiff claims the defendants had knowledge of patent infringement. 31 October 2023
Biotech
The Australian government has made numerous claims for damages against patentees for savings forgone when an interlocutory/preliminary injunction delays a generic's launch but the patent is invalidated or there is a finding of non-infringement. 26 October 2023
Biotech
Amy Baker Mandragouras’ (pictured) team follow her from Cooley | New counsel’s scientific expertise is “second-to-none” | Team has experience in strategic counselling and biotech patent portfolios. 19 October 2023
Americas
The firm's newest life sciences partners are patent litigators in biotech and pharma fields | Duo have secured Hatch-Waxman litigation victories. 19 October 2023
Pharma
Rocket Pharma says Lexeo Therapeutics hired its staff to keep clinical trial programme on track | Employees transferred confidential and proprietary information before leaving the company, it claims. 17 October 2023
Pharma
Gene-sequencing giant to be punished for defying EC authority by acquiring cancer treatment firm say FT sources | EC concerns over anti-competitive effects could scupper controversial deal. 10 October 2023
Biotech
Both attorneys have ‘exceptional experience’ in life sciences and previously practised at Dechert. 5 October 2023